Driving adoption of best practice clinical protocols for cardiovascular disease in Japan.
Client:
Top-10 Global Pharmaceutical Company
Challenge:
Address the uneven adoption of best practice clinical guidelines and protocols in atherosclerotic cardiovascular disease across Japan.
Impact:
Mapped clinical guidelines and current protocols for atherosclerotic cardiovascular disease across all prefectures in Japan.
Identified barriers to adoption for improved, evidence-based pathways based on the latest guidelines, which include use of a novel therapeutic agent.
Facilitated interactive workshops with Japanese commercial leads to develop solutions and engagement strategies to address these barriers.
Designed a capability-building program to prepare over 600 sales reps to implement these strategies and engage with major hospitals nationwide.
